#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "Private Ownership to Fraunhofer Institute SCAI"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Esther Wollert"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/cfd2ee89d1a71126da8b5f452544b7fe43be67e7/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET STATEMENT_GROUP = "Esther"

# Add statements below this comment

SET Citation = {"PubMed","Dis Model Mech. 2016 Aug 1;9(8):823-38. doi: 10.1242/dmm.024703.","27491084"}

SET Evidence = "The HSP40, HSP60 and HSP70 families were amongst the most
repressed chaperones, with HSP70s being the most repressed group
overall. However, in contrast with the broad spectrum of repressed
chaperone families, sHSPs and the TPR co-chaperone proteins were
the only families that were significantly induced."
#induced by aging
bp(MESH:Aging) -| p(HGNCGENEFAMILY:"DNAJ (HSP40) heat shock proteins")
bp(MESH:Aging) -| p(HGNC:HSPD1)
bp(MESH:Aging) -| p(FPLX:HSPA)
bp(MESH:Aging) -> p(HGNC:TPR)
bp(MESH:Aging) -> p(FPLX:HSPB)

SET Evidence = " Genetic approaches using
these disease models demonstrate that the chaperome plays a crucial
role in protecting cells from proteotoxicity."
a(MESH:"Molecular Chaperones") -| path(HBP:proteotoxicity)

SET Evidence = "Many studies based on model systems support a role for candidates
from each of the major chaperome families; HSP100, HSP90,
HSP70, HSP60, HSP40, sHSPs, and TPR-domain-containing
proteins in proteostasis."
bp(HBP:Proteostasis) -- p(HGNCGENEFAMILY:"DNAJ (HSP40) heat shock proteins")
bp(HBP:Proteostasis) -- p(HGNC:HSPD1)
bp(HBP:Proteostasis) -- p(FPLX:HSPA)
bp(HBP:Proteostasis) -- p(HGNC:TPR)
bp(HBP:Proteostasis) -- p(FPLX:HSPB)
bp(HBP:Proteostasis) -- p(FPLX:HSPB)
bp(HBP:Proteostasis) -- p(FPLX:HSP90)
bp(HBP:Proteostasis) -- p(HGNCGENEFAMILY:"AAA ATPases")

SET Evidence = "Early studies demonstrated that overexpression of a specific
human HSP70 (HSPA1L) in a Drosophila disease model
suppressed neurodegeneration associated with expression of
polyQ-containing forms of both ataxin 3 or androgen receptor,
and α -synuclein (Warrick et al., 1999; Chan et al., 2000, 2002;
Auluck et al., 2002). "
p(HGNC:HSPA1L) -| path(HP:Neurodegeneration)
path(HP:Neurodegeneration) -- p(HGNC:ATXN3, var("?"))
path(HP:Neurodegeneration) -- p(HGNC:AR, var("?"))
path(HP:Neurodegeneration) -- p(HGNC:SNCA, var("?"))

SET Evidence = " In a yeast model expressing the N-terminal
fragment of a polyQ-containing huntingtin protein, overexpression
of the yeast HSP70 (SSA1) reduced aggregate formation, whereas
the dominant-negative version of the fly homolog to HSPA1L,
Hsc4-K71S, enhanced neurodegeneration (Warrick et al., 1999;)"
p(FPLX:HSPA) -| p(HBP:"huntingtin aggregates")
p(HGNC:HSPA1L) -| path(HP:Neurodegeneration)

SET Evidence = " These studies revealed that an increase in levels of HSP70
reduced aggregation of disease-associated proteins, thus playing a
neuroprotective role."
p(FPLX:HSPA) -| path(MESH:"Protein Aggregation, Pathological")

SET Evidence = "For example,
overexpression of the human TPR domain-containing co-
chaperone CHIP suppresses neurodegeneration in fly models
expressing polyQ-containing versions of ataxin 1 and the
N-terminal huntingtin fragment (Al-Ramahi et al., 2006)."
#STUB1 is CHIP
p(HGNC:STUB1) -| path(HP:Neurodegeneration)

SET Evidence = "Likewise, overexpression of the yeast TPR-domain-containing co-
chaperone STI1 suppresses toxicity in a yeast model expressing the
expanded huntingtin fragment (Wolfe et al., 2013)."
p(UNIPROT:P15705) -| path(HBP:proteotoxicity)

SET Evidence = " The co-
chaperone HSP40 (dHdj-1 and SIS1) and the nucleotide exchange
factor SSE1 that specifically modulate HSP70 activity were also
shown to suppress toxicity and aggregation in yeast and fly disease
models (Chan et al., 2000; Krobitsch and Lindquist, 2000; Sadlish
et al., 2008)."
p(UNIPROT:P32589) reg act(p(FPLX:HSPA))
p(UNIPROT:P32589) -| path(HBP:proteotoxicity)
p(UNIPROT:P32589) -| path(MESH:"Protein Aggregation, Pathological")

SET Evidence = " In addition to co-chaperones, overexpression of the
human sHSP (HSPB7), a Caenorhabditis elegans HSP100
homolog (tor-2), and the yeast HSP60 subunit (CCT-1) and
HSP90 homolog (HSP82) reduced toxicity and aggregation (Cao
et al., 2005; Tam et al., 2006; Liang et al., 2008; Vos et al., 2010)."
p(HGNC:HSPB7) -| path(HBP:proteotoxicity)
p(HGNC:HSPB7) -| a(MESH:"Protein Aggregates")
p(UNIPROT:Q9XXG5) -| path(HBP:proteotoxicity)
p(UNIPROT:Q9XXG5) -| a(MESH:"Protein Aggregates")
p(UNIPROT:P12612) -| path(HBP:proteotoxicity)
p(UNIPROT:P12612) -| a(MESH:"Protein Aggregates")
p(UNIPROT:P02829) -| path(HBP:proteotoxicity)
p(UNIPROT:P02829) -| a(MESH:"Protein Aggregates")

SET Evidence = " HSP70s function
in a variety of basic cellular quality control and maintenance
processes, such as proper folding of newly synthesized proteins,
along with preventing protein misfolding and aggregation through
the binding of exposed hydrophobic residues."
p(FPLX:HSPA) -> bp(GO:"'de novo' protein folding")
p(FPLX:HSPA) -| bp(HBP:misfolding)
p(FPLX:HSPA) -| a(MESH:"Protein Aggregates")

SET Evidence = "Although HSP70 was not identified as a modifier of α -synuclein in
the screen studies we selected, directed overexpression of HSP70
has been shown to reduce α -synuclein-related proteotoxicity,
supporting a central role for HSP70 in diseases of protein
misfolding (Auluck et al., 2002)."
p(FPLX:HSPA) -| path(HBP:proteotoxicity)
p(FPLX:HSPA) -| a(HBP:"alpha-synuclein aggregates")

SET Evidence = " HSP40s play a fundamental role
as part of the HSP70-HSP40 system, as co-chaperones,
stimulating HSP70 ATP hydrolysis (Fig. 3) (Kampinga and
Craig, 2010; Kakkar et al., 2014)."
p(HGNCGENEFAMILY:"DNAJ (HSP40) heat shock proteins") -> act(p(FPLX:HSPA), ma(GO:"ATPase activity"))

SET Evidence = "The HSP70 and HSP40
family members exhibit significantly altered expression dynamics
during aging in the human brain, both being consistently repressed
with age (Brehme et al., 2014)."
bp(GO:aging) -| p(HGNCGENEFAMILY:"DNAJ (HSP40) heat shock proteins")
bp(GO:aging) -| p(FPLX:HSPA)

SET Evidence = " Among repressed genes, HSP40s
were found to show significant changes as a family, with 62% of
overall 48 HSP40 family members repressed in aging brain
(superior frontal gyrus), 51% repressed in AD, and 41% repressed
in both aging and AD. "
path(MESH:"Alzheimer Disease") -| p(HGNCGENEFAMILY:"DNAJ (HSP40) heat shock proteins")

SET Evidence = " Our summary (Table 1)
points towards specific sHSPs that play a prominent role in
misfolding diseases, as judged by frequency of observations,
including CRYAB, HSPB1, HSPB3 and HSPB8 (each 7×), HSPB6
(6×), and CRYAA (5×) (Fig. 1)."
p(FPLX:HSPB) -- bp(HBP:misfolding)

SET Evidence = "The importance of sHSPs in disease was
originally noted from the observations that HSPB1 and CRYAB
were overexpressed in AD brains (Shinohara et al., 1993; Renkawek
et al., 1994a,b) and HSPB1, CRYAB, HSPB6 and HSPB8 were
associated with AD plaques (Shao et al., 2012)."
SET MeSHAnatomy = "Brain"
path(MESH:"Alzheimer Disease") -> p(HGNC:HSPB1)
path(MESH:"Alzheimer Disease") -> p(HGNC:CRYAB)
UNSET MeSHAnatomy
p(HGNC:HSPB1) -- a(HBP:"amyloid-beta aggregates")
p(HGNC:CRYAB) -- a(HBP:"amyloid-beta aggregates")
p(HGNC:HSPB6) -- a(HBP:"amyloid-beta aggregates")
p(HGNC:HSPB8) -- a(HBP:"amyloid-beta aggregates")

SET Evidence = "Furthermore, sHSPs
were found to be consistently upregulated in the aging human brain
and in the context of neurodegenerative diseases (Brehme et al.,
2014). "
SET MeSHAnatomy = "Brain"
bp(GO:aging) -> p(FPLX:HSPB)
path(MESH:"Alzheimer Disease") -> p(FPLX:HSPB)
UNSET MeSHAnatomy

SET Evidence = "Therapeutic approaches to
overcome proteostasis deficiencies have largely focused on the
activation of HSF1, the heat shock transcription factor responsible
for simultaneous upregulation of the expression of multiple
molecular chaperones during stress (Calamini et al., 2011; Pierce
et al., 2013)."
p(HGNC:HSF1) -> bp(HBP:Proteostasis)

SET Evidence = "Multiple studies in model systems demonstrate
that overexpression of HSP70 can reduce toxicity and protein
aggregation."
p(FPLX:HSPA) -| path(HBP:proteotoxicity)
p(FPLX:HSPA) -| a(MESH:"Protein Aggregates")

SET Evidence = "Compounds such as the allosteric inhibitor of ATP-binding for the
inducible HSP70 isoform HSPA1A/HSPA1B, called HS-72, will
likely lead to beneficial consequences (Howe et al., 2014)."
a(PUBCHEM:"40009526") -| complex(p(HGNC:HSPA1A), a(CHEBI:ATP))
a(PUBCHEM:"40009526") -| complex(p(HGNC:HSPA1B), a(CHEBI:ATP))
